MÖLNDAL, Sweden--(BUSINESS WIRE)--Regulatory News:
Arcam AB (publ) (“Arcam” or the “Company”) today announces that it has completed a private placement of 175,000 new shares, providing the Company with approximately SEK 57 million before transaction costs.
The private placement has allowed Arcam to issue new shares to a limited number of Swedish and international institutional investors at a price of SEK 325 per share through a book-building procedure. The private placement of 175,000 shares is undertaken by virtue of the authorization given by the 2013 Annual General Meeting. The purpose of the private placement is to provide capital to enable an accelerated expansion and development of the Company, its market and products.
The new issue results in a share dilution of approximately 4.2 percent after completed issue. Through the issue, the number of shares in Arcam increases by 175 000 from 3 956 595 to 4 131 595 and the share capital increases by SEK 700,000 from SEK 15 826 381.50 to SEK 16 526 381.50.
Carnegie Investment Bank has acted as financial advisor to Arcam.
Important information
Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the constituent information in accordance with the rules and regulations prevailing in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Arcam AB (publ) securities in any jurisdiction, neither from Arcam AB (publ), Carnegie Investment Bank AB (publ) nor anyone else.
The above information has been made public in accordance with the Securities Market Act and/or the Financial Instruments Trading Act. The information was published on 12 June 2013 at 8.30 AM.
Arcam provides a cost-efficient Additive Manufacturing solution for production of metal components. The technology offers freedom in design combined with excellent material properties and high productivity. Arcam’s market is global with customers mainly in the orthopedic and aerospace industries. The company was founded in 1997 and is listed on NASDAQ OMX Stockholm, Sweden. Head office and production facilities are located in Mölndal, Sweden. Support offices are located in the US, UK, Italy and China.
Arcam AB • Krokslätts Fabriker 27A • SE-431 37 Mölndal, Sweden • 46-31-710 32 00 • www.arcam.com
This information was brought to you by Cision http://news.cision.com